LONDON, June 11 (Reuters) - Roche’s (ROG.VX) cancer drug Avastin is a cheap, effective treatment for preventing blindness and should be used routinely in countries that cannot afford the far more costly product Lucentis, researchers said on Friday.
LONDON, June 11 (Reuters) - Roche’s (ROG.VX) cancer drug Avastin is a cheap, effective treatment for preventing blindness and should be used routinely in countries that cannot afford the far more costly product Lucentis, researchers said on Friday.
